Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Gleason

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Prostate|September 6, 2001
Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancerA A Sinha, B J Quast, M J Wilson, et al.
The Prostate|January 1, 1989
Immunohistochemical localization of laminin in the basement membranes of normal, hyperplastic, and neoplastic human prostateA A Sinha, D F Gleason, M J Wilson, et al.
Cancer|June 20, 2001
Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysisM J Barry, P C Albertsen, M A Bagshaw, et al.
Cancer|January 15, 1992
Prediction of prognosis in untreated stage A2 prostatic carcinomaJ L Mohler, A W Partin, J I Epstein, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Prostate|September 6, 2001
Ratio of cathepsin B to stefin A identifies heterogeneity within Gleason histologic scores for human prostate cancerA A Sinha, B J Quast, M J Wilson, et al.
The Prostate|January 1, 1989
Immunohistochemical localization of laminin in the basement membranes of normal, hyperplastic, and neoplastic human prostateA A Sinha, D F Gleason, M J Wilson, et al.
Cancer|June 20, 2001
Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysisM J Barry, P C Albertsen, M A Bagshaw, et al.
Cancer|January 15, 1992
Prediction of prognosis in untreated stage A2 prostatic carcinomaJ L Mohler, A W Partin, J I Epstein, et al.
Pageof 4